专家集合包含Xeptagen公司。
专家集合是analyst-curated列表,突出了公司你需要知道的最重要的技术空间。
Xeptagen S.p.A.包含在1专家收集,包括组学。
组学
1267件
公司参与了捕获、测序和/或分析基因组、转录组、蛋白质组学和/或代谢组学数据
最新的Xeptagen公司。新闻
2017年9月8日
09:07美国东部时间2017年9月8日| BioPortfolio报告总结Xeptagen SpA Xeptagen是一个医疗设备公司,发现分子标记。公司生产诊断包的监控、检测和筛查的癌细胞。发展一个光电生物芯片测定肿瘤的分子标记;进行研究开发生物芯片的同时检测biomarkersIgM immunecomplexes。Xeptagen使用组合蛋白质组学技术发现预后预测和早期响应肿瘤标记物。公司经营通过一些医疗设备和研究机构来开发自己的产品。它执行研究治疗肝癌、结肠癌和前列腺癌。Xeptagen总部位于Marghera,意大利。这份报告是一个来源的数据、分析和可操作的情报公司的管道产品的组合。这份报告提供了关于公司的关键信息,它的主要产品和品牌。 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments The report analyzes all pipeline products in development for the company XEPTAGEN SpA The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date The report provides detailed description of products in development, technical specification and functions The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons to Buy: Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio To formulate effective Research Development strategies Develop marketentry and market expansion strategies Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio Note: Some sections may be missing if data is unavailable for the company Related Biotechnology, Pharmaceutical and Healthcare News
Xeptagen公司。常见问题(FAQ)
Xeptagen波斯公司。的竞争对手?
竞争对手的Xeptagen S.p.A.包括中国诊断医学、AllerQuest, Aviir,波节性,预测生物科学和12更多。
比较Xeptagen S.p.A.竞争对手
StageMark医疗保健公司,打算提供一个早期识别和炎症性疾病,如红斑狼疮的监控解决方案。
金丝雀基金会成立于2004年,由唐Listwin,一个成功的高科技高管误诊卵巢癌失去了他的母亲。也发现,尽管每年花费近100亿美元在美国癌症研究,绝大多数被分配给开发新的癌症治疗和照顾病人。令人惊讶的是,小资金提供给研究人员调查检测癌症的新方法,在其早期,可治愈的阶段。承诺不使用他的时间、精力,专业,热情,专业的网络,和自己的家庭基金会的资源来建立一个非盈利组织,将成功建立一个早期预警系统的癌症。他正在激情的基础是建立连接最好的癌症研究人员和企业家和风险资本家,他们的突破将会挽救生命的机会。并招募了Dr.Lee哈特韦尔,2001年诺贝尔奖得主,帮助形成了金丝雀从最杰出的科学团队,科学研究人员可以从各种各样的学科。科学团队成员来自不同领域和机构广泛满足定期分享想法和突破。金丝雀设计了一个简单的过程,为团队成员提供资金和工具来完成自己的既定目标快速和直接适用的结果。工具包括软件共享数据,专门的网站,项目管理支持,季度协作会议和项目审查。一个科学团队做出的决定就是选择卵巢癌作为创建一个原型早期检测血液测试来检测微量的蛋白质生物标记物所产生的癌症。 Ovarian cancer was chosen as it is generally considered asymptomatic until late stage and has relatively low occurrence. Knowledge, techniques, and data gathered from the Ovarian Cancer Program are being leveraged to expand into other types of cancers (Pancreatic, Prostate and Lung). In addition to blood tests, the Science Team is working on advancing imaging techniques and agents for general body scanning technology using PET, Ultrasound and other imaging modalities for pinpointing the exact cancer location in order to eradicate it while it is still small and before it has spread. Canary hopes that by delivering on a effective test for early detection of cancer it will spur a dramatic increase of funds into the early detection field from the National Cancer Institute and the venture capital community so that products based on this research will arrive faster and save millions of lives per year.
波节性是专注于发展高度预测测试使biologically-informed癌症和自身免疫性疾病患者的临床治疗决策。
Litholink提供代谢评估肾脏结石患者。
功名之外在圣地亚哥生物医学公司开发产品的检测、鉴定和治疗疾病。该公司正在开发技术,旨在研究和管理重大疾病包括癌症、心血管疾病和肝胆的疾病。功名之外的最新产品,膜孔,彻底改革了体内成像方式用于基础研究和药物开发。最初成立于1997年,MetaProbe LLC研究公司技术和加州理工学院,功名之外生物医学已经涵盖范围广泛的药物传输和医学成像技术。先进的研究技术公司,加拿大医疗器械公司,收购实质上所有的成像技术和产品在2006年3月功名之外的资产。艺术正积极推动膜孔的产品线。
冬青的设备是一种疾病标记测试平台用于医疗点。